GHRP-6 (5mg x 10), CJC-1295 no DAC (5mg x 10)

$726.00

& Free Shipping

GHRP-6 and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary signaling mechanisms. GHRP-6 is a hexapeptide growth hormone secretagogue that binds the growth hormone secretagogue receptor (GHS-R1a), activating Gq/PLC-dependent calcium signaling pathways involved in GH release. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling. Preclinical studies demonstrate that combined GHS-R1a agonists and GHRH analogs are used to study synergistic somatotropic signaling, hypothalamic–pituitary feedback, and peptide-mediated endocrine regulation.

For research use only. Not for human consumption.

References:
Frohman LA et al., Endocr Rev, 2001 22(6):606–648
Bowers CY et al., Ann NY Acad Sci, 1998 865:244–249
Smith RG et al., Science, 1997 275(5304):1261–1264

Category:

What you’re asking for

GHRP-6 (5mg × 10) + CJC-1295 no DAC (5mg × 10)

This is a dual growth hormone secretagogue stack commonly sold in the peptide research market:

  • GHRP-6 → ghrelin receptor (strong GH + appetite signaling)
  • CJC-1295 no DAC → GHRH analog (pituitary GH release signal)

What this combo actually is (research context)

  • Stimulates growth hormone release via ghrelin receptor
  • Also strongly linked to increased appetite signaling
  • One of the earlier GH-releasing peptides studied in lab research

  • Stimulates GH release via GHRH receptor
  • Short-acting → produces pulsatile GH secretion patterns

Why they’re commonly paired

In research discussions, this pairing is used because:

  • Two different receptor pathways → stronger GH pulse signaling
  • Mimics more natural hormone release patterns
  • Studied for metabolic, recovery, and endocrine signaling models

Example lab formulations often describe:

  • GHRP-6 + Mod GRF (CJC-1295 no DAC) in equal 5mg blends per vial (peptide-works.com)

What “5mg × 10 vials” actually means

This usually indicates:

  • 10 separate vials per compound
  • Each vial contains 5mg freeze-dried peptide powder
  • Total batch size:
    • 50mg GHRP-6
    • 50mg CJC-1295 no DAC

These are sold as lyophilized research chemicals, not finished medicines.

Most vendors explicitly state:

“For laboratory research use only, not for human consumption” (Palmetto Peptides)


Important reality check

Even though they’re heavily marketed online:

  • ❌ Not FDA-approved
  • ❌ Not a licensed medication or supplement
  • ❌ No standardized human dosing protocols
  • ✔ Classified as research peptides

Risks people often ignore

  • No regulated manufacturing consistency
  • Mislabeling of peptide content is common
  • No long-term safety data in non-clinical use
  • Effects on GH/IGF-1 axis are not fully predictable outside research settings

Bottom line

  • is a research-only combination used to study growth hormone release via two complementary pathways, but “5mg × 10 vial” products are unregulated laboratory materials—not approved medicines, supplements, or safe consumer products.

ghrp 6 (5mg x 10), cjc 1295 no dac (5mg x 10)ghrp 6 (5mg x 10), cjc 1295 no dac (5mg x 10)ghrp 6 (5mg x 10), cjc 1295 no dac (5mg x 10)

Shopping Cart